Ivana Heřmanová

729 total citations
16 papers, 406 citations indexed

About

Ivana Heřmanová is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Ivana Heřmanová has authored 16 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 4 papers in Immunology. Recurrent topics in Ivana Heřmanová's work include Acute Lymphoblastic Leukemia research (7 papers), Biochemical and Molecular Research (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Ivana Heřmanová is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Biochemical and Molecular Research (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Ivana Heřmanová collaborates with scholars based in Czechia, Spain and United Kingdom. Ivana Heřmanová's co-authors include Jan Trka, Júlia Starková, Markéta Žaliová, Jitka Fučíková, Simona Partlová, Jiřina Bartůňková, Milan Houška, Anna Fialová, Luděk Sojka and Pierre‐François Cartron and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Ivana Heřmanová

14 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ivana Heřmanová Czechia	9	198	132	97	84	52	16	406
Julie Ross Canada	10	373 1.9×	58 0.4×	86 0.9×	51 0.6×	61 1.2×	14	497
Changchuin Mao United States	11	217 1.1×	303 2.3×	165 1.7×	49 0.6×	54 1.0×	20	573
Susan K. Rathe United States	12	234 1.2×	87 0.7×	100 1.0×	84 1.0×	67 1.3×	18	390
Nicola J. MacLaine United Kingdom	9	293 1.5×	108 0.8×	152 1.6×	42 0.5×	39 0.8×	10	435
Yanjun Gu China	11	348 1.8×	77 0.6×	166 1.7×	208 2.5×	52 1.0×	24	532
Marja‐Riitta Väisänen Finland	11	169 0.9×	90 0.7×	97 1.0×	84 1.0×	56 1.1×	12	392
Jens Rüschmann Canada	12	301 1.5×	220 1.7×	70 0.7×	46 0.5×	19 0.4×	15	514
Helicia Paz United States	10	308 1.6×	102 0.8×	117 1.2×	79 0.9×	19 0.4×	12	463
Margherita Ghisi Australia	9	453 2.3×	105 0.8×	217 2.2×	222 2.6×	36 0.7×	11	663
Kazuyo Yasuda Japan	15	351 1.8×	124 0.9×	279 2.9×	128 1.5×	49 0.9×	24	585

Countries citing papers authored by Ivana Heřmanová

Since Specialization

Citations

This map shows the geographic impact of Ivana Heřmanová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana Heřmanová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana Heřmanová more than expected).

Fields of papers citing papers by Ivana Heřmanová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivana Heřmanová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana Heřmanová. The network helps show where Ivana Heřmanová may publish in the future.

Co-authorship network of co-authors of Ivana Heřmanová

This figure shows the co-authorship network connecting the top 25 collaborators of Ivana Heřmanová. A scholar is included among the top collaborators of Ivana Heřmanová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivana Heřmanová. Ivana Heřmanová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Heřmanová, Ivana, et al.. (2022). PTEN/PI3K/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to l-asparaginase. Scientific Reports. 12(1). 4043–4043. 14 indexed citations

Roberts, Jennie, Alena Pecinová, Petr Pecina, et al.. (2022). Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy. Blood Advances. 7(10). 2228–2236. 2 indexed citations

Roberts, Jennie, Alena Pecinová, Petr Pecina, et al.. (2022). Restored Biosynthetic Pathways Induced By MSCs Serve As Rescue Mechanism in Leukemia Cells after L-Asparaginase Therapy. Blood. 140(Supplement 1). 2908–2909. 1 indexed citations

Valcárcel-Jiménez, Lorea, Eva Crosas‐Molist, Laura Camacho, et al.. (2019). PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control. Cancer Research. 79(24). 6153–6165. 49 indexed citations

Cortázar, Ana R., Verónica Torrano, Natalia Martín-Martín, et al.. (2018). CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets. Cancer Research. 78(21). 6320–6328. 63 indexed citations

Valcárcel-Jiménez, Lorea, Natalia Martín-Martín, Ana R. Cortázar, et al.. (2018). Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer. Cell Death and Disease. 9(10). 1041–1041. 15 indexed citations

Starková, Júlia, et al.. (2017). Altered Metabolism of Leukemic Cells: New Therapeutic Opportunity. International review of cell and molecular biology. 336. 93–147. 8 indexed citations

Stuchlý, Jan, Veronika Kanderová, Marcela Vlková, et al.. (2017). Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia. Scientific Reports. 7(1). 39710–39710. 21 indexed citations

Heřmanová, Ivana, Amaia Arruabarrena-Aristorena, Karel Vališ, et al.. (2015). Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells. Leukemia. 30(1). 209–218. 38 indexed citations

10.

Pecinová, Alena, Ivana Heřmanová, David Pajuelo Reguera, et al.. (2015). L-Asparaginase More Effectively Targets Leukemic Cells with Low Glycolytic Activity. Blood. 126(23). 1285–1285. 1 indexed citations

11.

Fučíková, Jitka, Irena Moserová, Iva Truxová, et al.. (2014). High hydrostatic pressure induces immunogenic cell death in human tumor cells. International Journal of Cancer. 135(5). 1165–1177. 139 indexed citations

12.

Fučíková, Jitka, Irena Moserová, Iva Truxová, et al.. (2014). Article title: High hydrostatic pressure induces immunogenic cell death in human tumor cells.. 1 indexed citations

13.

Heřmanová, Ivana, Karel Vališ, Hana Nůsková, et al.. (2014). L-Asparaginase Causes Metabolic Reprogramming in ALL Cells. Blood. 124(21). 922–922.

14.

Kanderová, Veronika, Eva Froňková, Jan Stuchlý, et al.. (2013). Subgroup of Common Variable Immunodeficiency patients with distinct clinical and biological features revealed by B-cell immunophenotyping. Frontiers in Immunology. 4.

15.

Heřmanová, Ivana, Markéta Žaliová, Jan Trka, & Júlia Starková. (2012). Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase. Experimental Hematology. 40(8). 657–665. 38 indexed citations

16.

Starková, Júlia, et al.. (2011). Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling. Haematologica. 96(6). 820–828. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact